Theralase Technologies Inc (TLTFF)

[citoyen]

On May 26, 2017, Theralase announced that the independent Data and Safety Monitoring Board (“DSMB”) unanimously decided that the primary and secondary objectives for the first part of the Phase Ib NMIBC clinical study (“Study”) have successfully been met.

Understand that stock may be somewhat "dead money" until part 2 of Phase 1b completed and results reported, but...this is amazing news and what we have been waiting for. Given the enormity of this development -- and the now greater likelihood of success for pt 2 of the trial, frankly a bit surprised by the sell-off. fwiw and unless i'm missing something, think it will be short-lived...